Telocytes as a source of progenitor cells in regeneration and repair through granulation tissue

Current Stem Cell Research and Therapy

Volumn 11, Issue 5, 2016, Pages 395-403

  Díaz Flores, Lucio ^a   Gutiérrez, Ricardo ^a   García, Maria Pino ^b   González, Miriam ^a   Madrid, Juan Francisco ^c  

^a UNIVERSIDAD DE LA LAGUNA   (Spain)

^b Grupo Hospiten   (Spain)

^c UNIVERSITY OF MURCIA   (Spain)

Author keywords

CD34; Mesenchymal cells; Myofibroblasts; Repair; Telocytes

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN;

ARTICLE; CD34 SELECTION; CELL ACTIVATION; CELL PROLIFERATION; CHOROID PLEXUS; DEGENERATION; ENCAPSULATION; EX VIVO STUDY; EYE; FIBROBLAST; FIBROSIS; GASTROINTESTINAL TRACT; GRANULATION TISSUE; HEART; HUMAN; INFLAMMATION; LIVER; MYOFIBROBLAST; PAPULE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYSTEM; SKIN; STEM CELL; STROMA CELL; TELOCYTE; TISSUE REGENERATION; TISSUE REPAIR; ANIMAL; CELL CYCLE; CYTOLOGY; PATHOLOGY; REGENERATION; ULTRASTRUCTURE; WOUND HEALING;

ANIMALS; CELL CYCLE; GRANULATION TISSUE; HUMANS; REGENERATION; STEM CELLS; TELOCYTES; WOUND HEALING;

EID: 84974712332     PISSN: 1574888X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1574888X10666151001115111     Document Type: Article

References (100)

1. Popescu LM, Faussone-Pellegrini MS. TELOCYTES-a case of serendipity: the winding way from Interstitial Cells of Cajal (ICC), via Interstitial Cajal-Like Cells ICLC to TELOCYTES. J Cell Mol Med 2010; 14(4): 729-40.
2. Popescu LM. Telocytes-A novel type of interstitial cells. In: Braisant O, Wakamatsu H, Kang I, Allegaert K, Lenbury Y, Wacholtz A, editors. Recent researches in modern medicine-HISTEM 2011. Cambridge, UK: WSEAS Press 2011; p 424-32.
3. Popescu LM. The tandem: Telocytes-Stem cells. Int J Biol Biomed Eng 2011; 5(2): 83-92
4. Popescu LM, Manole E, Serboiu CS, et al. Identification of telocytes in skeletal muscle interstitium: Implication for muscle regeneration. J Cell Mol Med 2011b; 15(6): 1379-92.
5. Popescu LM, Gherghiceanu M, Suciu LC, et al. Telocytes and putative stem cells in the lungs: electron microscopy, electron tomography and laser scanning microscopy. Cell Tissue Res 2011a; 345(3): 391-403.
6. Gherghiceanu M, Popescu LM. Heterocellular communication in the heart: electron tomography of telocyte-myocyte junctions. J Cell Mol Med 2011; 15(4): 1005-11.
7. Manole CG, Cismasiu V, Gherghiceanu M, et al. Experimental acute myocardial infarction: Telocytes involvement in neoangiogenesis. J Cell Mol Med 2011; 158(11): 2284-96.
8. Ceafalan L, Gherghiceanu M, Popescu LM, et al. Telocytes in human skin--are they involved in skin regeneration? J Cell Mol Med 2012; 16(7): 1405-20.
9. Diaz-Flores L, Gutierrez R, Garcia MP, et al. Cd34+ stromal cells/fibroblasts/fibrocytes/telocytes as a tissue reserve and a principal source of mesenchymal cells. Location, morphology, function and role in pathology. Histol Histopathol 2014; 29(7): 831-70.
10. Díaz-Flores L, Gutiérrez R, Lizartza K, et al. Behavior of in situ human native adipose tissue CD34+ stromal/progenitor cells during different stages of repair. Tissue-resident CD34+ stromal cells as a source of myofibroblasts. Anat Rec (Hoboken) 2015; 298(5): 917-30.
11. Díaz-Flores L, R. Gutiérrez, MP García, et al. Human resident CD34+ stromal cells/telocytes have progenitor capacity and are a source of αsma+ cells during repair. Histol Histopathol 2015; 30(5): 615-27.
12. Faussone-Pellegrini MS, Popescu LM. Telocytes BioMol Concepts 2011; 2(6): 481-9.
13. Sidney LE, Branch MJ, Dunphy SE, et al. Concise review: evidence for CD34 as a common marker for diverse progenitors. Stem Cells 2014; 32(6): 1380-9.
14. Lin CS, Xin ZC, Dai J, et al. Commonly used mesenchymal stem cell markers and tracking labels: Limitations and challenges. Histol Histopathol 2013; 28(9): 1109-16.
15. Díaz-Flores L Jr, Gutierrez R, Madrid JF, et al. Adult stem cells and repair through granulation tissue. Front Biosci (Landmark Ed). 2009; 14: 1433-70.
16. Díaz-Flores L, Gutiérrez R, Madrid JF, et al. Adult Stem and Transit-Amplifying Cells in Repair through Granulation Tissue: Role of the Pericytic Vasculature Niche. Chapter 6, pp 158-185. In: Stem Cell, Regenerative Medicine and Cancer. Singh S.R. Nova Science Publishers, Inc. New York, 2011.
17. Cretoiu SM, Popescu LM. Telocytes revisited. Biomol Concepts 2014; 5(5): 353-69.
18. Cantarero I, Luesma MJ, Junquera C. The primary cilium of telocytes in the vasculature: electron microscope imaging. J Cell Mol Med 2011; 15(12): 2594-600.
19. Zheng Y, Zhang M, Qian M, Wang L, Cismasiu VB, Bai C, Popescu LM, Wang X. Genetic comparison of mouse lung telocytes with mesenchymal stem cells and fibroblasts. J Cell Mol Med 2013; 17(4): 567-77.
20. Zheng Y, Cretoiu D, Yan G, Cretoiu SM, Popescu LM, Fang H, Wang X. Protein profiling of human lung telocytes and microvascular endothelial cells using iTRAQ quantitative proteomics. J Cell Mol Med 2014; 18(6): 1035-59.
21. Popescu LM, Gherghiceanu M, Cretoiu D, et al. The connective connection: interstitial cells of Cajal (ICC) and ICC-like cells establish synapses with immunoreactive cells. Electron microscope study in situ. J Cell Mol Med 2005; 9(3): 714-30.
22. Mandache E, Popescu LM, Gherghiceanu M. Myocardial interstitial Cajal-like cells (ICLC) and their nanostructural relationships with intercalated discs: shed vesicles as intermediates. J Cell Mol Med 2007; 11(5): 1175-84.
23. Nicolescu MI, Popescu LM. Telocytes in the interstitium of human exocrine pancreas: ultrastructural evidence. Pancreas. 2012; 41(6): 949-56.
24. Nicolescu MI, Bucur A, Dinca O, et al. Telocytes in parotid glands. Anat Rec (Hoboken) 2012; 295(3): 378-85.
25. Fertig ET, Gherghiceanu M, Popescu LM. Extracellular vesicles release by cardiac telocytes: electron microscopy and electron tomography. J Cell Mol Med 2014; 18(10): 1938-43.
26. Hinescu ME, Popescu LM, Gherghiceanu M, et al. Interstitial Cajal-like cells in rat mesentery: an ultrastructural and immunohistochemical approach. J Cell Mol Med 2008; 12(1): 260-70.
27. Cretoiu SM, Cretoiu D, Marin A, et al. Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction 2013; 145(4): 357-70.
28. Pieri L, Vannucchi MG. Faussone-Pellegrini MS. Histochemical and ultrastructural characteristics of an interstitial cell type different from ICC and resident in the muscle coat of human gut. J Cell Mol Med 2008; 12(5B): 1944-55.
29. Vannucchi MG, Traini C, Manetti M, et al. Telocytes express PDGFRα in the human gastrointestinal tract. J Cell Mol Med 2013; 17(9): 1099-108.
30. Diaz-Flores L, Gutiérrez R, Sáez FJ, et al. Telocytes in neuromuscular spindles. J Cell Mol Med 2013; 17(4): 457-65.
31. Bani D, Formigli L, Gherghiceanu M, et al. Telocytes as supporting cells for myocardial tissue organization in developing and adult heart. J Cell Mol Med 2010; 14(10): 2531-8.
32. Faussone-Pellegrini MS, Bani D. Relationships between telocytes and cardiomyocytes during pre-and post-natal life. J Cell Mol Med. 2010; 14(5): 1061-3.
33. Gherghiceanu M, Hinescu ME, Popescu LM. Myocardial interstitial Cajal-like cells (ICLC) in caveolin-1 KO mice. J Cell Mol Med 2009; 13(1): 202-6.
34. Popescu LM, Nicolescu MI. Telocytes and stem cells. In: Coeli dos Santos Goldenberg R, Campos de Carvalho AC, editors. Resident Stem Cells and Regenerative Therapy. Academic Press/Elsevier; 2013. p. 205-31.
35. Gherghiceanu M, Popescu LM. Cardiac telocytes-their junctions and functional implications. Cell Tissue Res 2012; 348(2): 265-79.
36. Yamazaki K, Eyden BP. Ultrastructural and immunohistochemical observations on intralobular fibroblasts of human breast, with observations on the CD34 antigen. J Submicroscop Cytol Pathol 1995; 27(3): 309-23.
37. Díaz-Flores L, Gutiérrez R, García MP, et al. Uptake and intracytoplasmic storage of pigmented particles by human CD34+ stromal cells/telocytes: endocytic property of telocytes. J Cell Mol Med 2014; 18(12): 2478-87.
38. Wang F, Song Y, Bei Y, et al. Telocytes in liver regeneration: possible roles. J Cell Mol Med. 2014; 18(9): 1720-6
39. Xiao J, Wang F, Liu Z, et al. Telocytes in liver: electron microscopic and immunofluorescent evidence. J Cell Mol Med. 2013; 17(12):1537-42.
40. Popescu LM, Gherghiceanu M, Manole CG, et al. Cardiac renewing: interstitial Cajal-like cells nurse cardiomyocyte progenitors in epicardial stem cell niches. J Cell Mol Med 2009; 13(5): 866-86.
41. Zhou J, Wang Y, Zhu P, et al. Distribution and characteristics of telocytes as nurse cells in the architectural organization of engineered heart tissues. Sci China Life Sci 2014; 57(2): 241-7.
42. Luesma MJ, Gherghiceanu M, Popescu LM. Telocytes and stem cells in limbus and uvea of mouse eye. J Cell Mol Med 2013; 17(8): 1016-24.
43. Tummala P, Arnsdorf EJ, Jacobs CR. The Role of Primary Cilia in Mesenchymal Stem Cell Differentiation: A Pivotal Switch in Guiding Lineage Commitment. Cell Mol Bioeng 2010; 3(3): 207-12.
44. Erdag G, Qureshi HS, Patterson JW, et al. Solitary fibrous tumors of the skin: A clinicopathologic study of 10 cases and review of the literature. J Cut Dis 2007; 34(11): 844-50.
45. Bucala R, Spiegel LA, Chesney J, et al. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994; 1(1): 71-81.
46. Abe R, Donnelly SC, Peng T, et al. Peripheral blood fibrocytes: Differentiation pathway and migration to wound sites. J Immunol 2001; 166(12): 7556-62.
47. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11(6): 427-35.
48. Díaz-Flores L, Gutierrez R, Madrid JF, et al. Pericytes. Morphofunction, interactions and pathology in a quiescent and activated mesenchymal cell niche. Histol Histopathol 2009a; 24(7): 909-69.
49. Aiba S, Tagami H. Inverse correlation between CD34 expression and proline-4-hydroxylase immunoreactivity on spindle cells noted in hypertrophic scars and keloids. J Cutan Pathol 1997; 24(2): 65-9.
50. Jiménez-Heffernan JA, Aguilera A, Aroeira LS, et al. Immunohistochemical characterization of fibroblast subpopulations in normal peritoneal tissue and in peritoneal dialysis-induced fibrosis. Virch Arch 2004; 444(3): 247-56.
51. Schmidt M, Sun G, Stacey MA, et al. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003; 171(1): 380-9.
52. Phillips RJ, Burdick MD, Hong K, et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114(3): 438-46.
53. Gomperts BN, Belperio JA, Rao PN, et al. Circulating progenitor epithelial cells traffic via CXCR4/CXCL12 in response to airway injury. J Immunol 2006; 176(3): 1916-27.
54. Quan TE, Cowper S, Wu SP, et al. Circulating fibrocytes: collagensecreting cells of the peripheral blood. Int J Biochem Cell Biol 2004; 36(4): 598-606.
55. Nakayama H, Enzan H, Miyazaki E, et al. Differential expression of CD34 in normal colorectal tissue, peritumoral inflammatory tissue, and tumour stroma. J Clin Pathol 2000; 53(8): 626-9.
56. Nakayama H, Enzan H, Miyazaki E, et al. CD34 positive stromal cells in gastric adenocarcinomas. J Clin Pathol 2001; 54(11): 846-8.
57. Nakayama H, Enzan H, Yamamoto M, et al. CD34-positive stromal cells in primary lung carcinomas. Oncol Rep 2003; 10(5): 1313-6.
58. Barth PJ, Ebrahimsade S, Ramaswamy A, et al. CD34+ fibrocytes in invasive ductal carcinoma, ductal carcinoma in situ, and benign breast lesions. Virch Arch 2002b; 440(3): 298-303.
59. Barth PJ, Ramaswamy A, Moll R. CD34(+) fibrocytes in normal cervical stroma, cervical intraepithelial neoplasia III, and invasive squamous cell carcinoma of the cervix uteri. Virch. Arch 2002a; 441(6): 564-8.
60. Barth PJ, Schenckzu Schweinsberg T, Ramaswamy A, et al. CD34+ fibrocytes, alpha-smooth muscle antigen-positive myofibroblasts, and CD117 expression in the stroma of invasive squamous cell carcinomas of the oral cavity, pharynx, and larynx. Virch Arch 2004; 444(3): 231-4.
61. Barth PJ, Moll R, Ramaswamy A. Stromal remodeling and SPARC (secreted protein acid rich in cysteine) expression in invasive ductal carcinomas of the breast. Virchows Arch 2005b; 446(5): 532-6.
62. Ramaswamy A, Moll R, Barth PJ. CD34+ fibrocytes in tubular carcinomas and radial scars of the breast. Virch Arch 2003; 443(4): 536-40.
63. Kuroda N, Jin YL, Hamauzu T, et al. Consistent lack of CD34-positive stromal cells in the stroma of malignant breast lesions. Histol Histopathol 2005c; 20(1): 707-12.
64. Kuroda N, Nakayama H, Miyazaki E, et al. The distribution of CD34-positive stromal cells and myofibroblasts in colorectal carcinoid tumors. Histol Histopathol 2005a; 20(1): 27-33.
65. Ebrahimsade S, Westhoff CC, Barth PJ. CD34+ fibrocytes are preserved in most invasive lobular carcinomas of the breast. Pathol Res Prac 2007; 203(9): 695-8.
66. Nimphius W, Moll R, Olbert P, et al. CD34+ fibrocytes in chronic cystitis and noninvasive and invasive urothelial carcinomas of the urinary bladder. Virch Arch 2007; 450(2): 179-85.
67. Wessel C, Westhoff CC, Nowak K, et al. CD34(+) fibrocytes in melanocytic nevi and malignant melanomas of the skin. Virch Arch 2008; 453(5): 485-9.
68. Chauhan H, Abraham A, Phillips JR, et al. There is more than one kind of myofibroblast: Analysis of CD34 expression in benign, in situ, and invasive breast lesions. J Clin Pathol 2003; 56(4): 271-6.
69. Barth PJ, Westhoff CC. CD34+ fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2007; 2(3): 221-7.
70. Díaz-Flores L, Gutierrez R, Garcia MP, et al. Myopericytoma and arterial intimal thickening: The relationship between myopericytes and myointimal cells. J Cut Pathol 2011; 38(11): 857-64.
71. Díaz-Flores L, Gutiérrez R, del Pino García M, et al. CD34-positive fibroblasts in Reinke's edema. Laryngoscope 2014; 124(3): E73-80.
72. Barth PJ, Koster H, Moosdorf R. CD34+ fibrocytes in normal mitral valves and myxomatous mitral valve degeneration. Pathol Res Pract 2005a; 201(4): 301-4.
73. Yang Y, Sun W, Wu SM, et al. Telocytes in human heart valves. J Cell Mol Med 2014; 18(5): 759-65.
74. Sengenes C, Lolmede K, Zakaroff-Girard A, et al. Preadipocytes in the human subcutaneous adipose tissue display distinct features from the adult mesenchymal and hematopoietic stem cells. J Cell Physiol 2005; 205(1): 114-22.
75. Mitchell JB, McIntosh K, Zvonic S, et al. Immunophenotype of human adipose-derived cells: temporal changes in stromalassociated and stem cell-associated markers. Stem Cells 2006; 24(2): 376-85.
76. Suga H, Matsumoto D, Eto H, et al. Functional implications of CD34 expression in human adipose-derived stem/progenitor cells. Stem cells Dev 2009; 18(8): 1201-10.
77. Tarnok A, Ulrich H, Bocsi J. Phenotypes of stem cells from diverse origin. Cytometry A 2010; 77(1): 6-10.
78. Braun J, Kurtz A, Barutcu N, et al. Concerted regulation of CD34 and CD105 accompanies mesenchymal stromal cell derivation from human adventitial stromal cell. Stem Cells Dev 2013; 22(5): 815-27.
79. Zimmerlin L, Donnenberg VS, Rubin JP, et al. Mesenchymal markers on human adipose stem/progenitor cells. Cytometry A 2013; 838(1): 134-40.
80. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng 2001; 7(2): 211-28.
81. Zuk PA, Zhu M, Ashjian P, et al. Human adipose tissue is a source of multipotent stem cells. Mol Biol Cell 2002; 13(1): 4279-95.
82. Halvorsen YC, Wilkison WO, Gimble JM. Adipose-derived stromal cells--their utility and potential in bone formation. Int J Obes Relat Metab Disord 2000; 24(Suppl) 4: S41-44.
83. Erickson GR, Gimble JM, Franklin DM, et al. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun 2002; 290(2): 763-769.
84. Mizuno H, Zuk PA, Zhu M, et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002; 109(1): 199-209.
85. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy 2003; 5(5): 362-9.
86. Hicok KC, Du Laney TV, Zhou YS, et al. Human adipose-derived adult stem cells produce osteoid in vivo. Tissue Eng 2004; 10(3-4): 371-80.
87. Justesen J, Pedersen SB, Stenderup K, et al. Subcutaneous adipocytes can differentiate into bone-forming cells in vitro and in vivo. Tissue Eng 2004; 10(3-4): 381-91.
88. Gimble JM, Katz AJ, Bunnell BA. Adipose-derived stem cells for regenerative medicine. Circ Res 2007; 100(9): 1249-60.
89. Daher SR, Johnstone BH, Phinney DG, et al. Adipose stromal/stem cells: basic and translational advances: the IFATS collection. Stem Cells 2008; 26(10): 2664-5.
90. Boquest AC, Shahdadfar A, Fronsdal K, et al. Isolation and transcription profiling of purified uncultured human stromal stem cells: alteration of gene expression after in vitro cell culture. Mol Biol Cell 2005; 16(3): 1131-41.
91. Lin G, Garcia M, Ning H, et al. Defining stem and progenitor cells within adipose tissue. Stem cells Dev 2008; 17(6): 1053-63.
92. Rodeheffer MS., Birsoy K, Friedman JM. Identification of white adipocyte progenitor cells in vivo. Cell 2008; 135(2): 240-9.
93. Zimmerlin L, Donnenberg VS, Pfeifer ME, et al. Stromal vascular progenitors in adult human adipose tissue. Cytometry A 2010; 77(1): 22-30.
94. Li H, Zimmerlin L, Marra KG, et al. Adipogenic potential of adipose stem cell subpopulations. Plast Reconstr Surg 2011; 128(3): 663-672.
95. Maumus M, Peyrafitte JA, D'Angelo R, et al. Native human adipose stromal cells: localization, morphology and phenotype. Int J Obes (Lond) 2011; 35(9): 1141-53.
96. Bassi G, Pacelli L, Carusone R, et al. Adipose-derived stromal cells (ASCs). Transfus Apher Sci 2012; 47(2): 193-8.
97. Bourin P, Bunnell BA, Casteilla L, et al. Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 2013; 15(6): 641-8.
98. Milia AF, Ruffo M, Manetti M, et al. Telocytes in Crohn's disease. J Cell Mol Med 2013; 17(12): 1525-36.
99. Lin CS, Ning H, Lin G, et al. Is CD34 truly a negative marker for mesenchymal stromal cells? Cytotherapy 2012; 14(10): 1159-63.
100. Lin G, Xu RH. Progresses and challenges in optimization of human pluripotent stem cell culture. Curr Stem Cell Res Ther 2010; 5(3): 207-14.